These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27784965)

  • 1. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y; Liu YH; Hu YY; Chen L; Li JM
    World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
    Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.
    Yu W; Ma Y; Shankar S; Srivastava RK
    Oncotarget; 2016 Sep; 7(36):57783-57797. PubMed ID: 27472393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
    Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
    FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer.
    Yu W; Srivastava R; Srivastava S; Ma Y; Shankar S; Srivastava RK
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
    Yu W; Ma Y; Shankar S; Srivastava RK
    Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
    Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
    PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR‑3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2.
    Yang D; Li R; Xia J; Li W; Zhou H
    Mol Med Rep; 2018 Dec; 18(6):4847-4854. PubMed ID: 30320357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
    Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
    Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.
    Wang S; Zhou J; Wang XY; Hao JM; Chen JZ; Zhang XM; Jin H; Liu L; Zhang YF; Liu J; Ding YQ; Li JM
    J Pathol; 2009 Sep; 219(1):114-22. PubMed ID: 19557828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2.
    Yang MH; Yu J; Chen N; Wang XY; Liu XY; Wang S; Ding YQ
    PLoS One; 2013; 8(12):e85353. PubMed ID: 24386467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis.
    Yang MH; Yu J; Jiang DM; Li WL; Wang S; Ding YQ
    J Transl Med; 2014 May; 12():109. PubMed ID: 24884732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
    Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
    Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.
    Fang XF; Hou ZB; Dai XZ; Chen C; Ge J; Shen H; Li XF; Yu LK; Yuan Y
    World J Gastroenterol; 2013 Apr; 19(15):2331-9. PubMed ID: 23613626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer.
    Gu J; Wang G; Liu H; Xiong C
    Cell Prolif; 2018 Aug; 51(4):e12455. PubMed ID: 29701273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.